ERCC1 Expression in Lung Cancer: Excision repair cross-complementation group 1 (ERCC1) expression levels in NSCLC have been explored as a predictive biomarker for response to platinum-based chemotherapy [408]. This evidence concerns the gene ERCC1 and lung cancer.